Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 

Trackinsight: Cathie’s ARK fleet sails to green waters

10/20/2021 | 10:00am EST

The top performer ARK Genomic Revolution ETF or ARKG, invests in industries of the health care sector, including companies involved in the biotechnology industry.

Cathie Wood’s popular thematic ETFs ARK Genomic Revolution ETF (+3.44%), ARK Innovation ETF (+2.18%), ARK Autonomous Technology & Robotics ETF (+1.92%), ARK Next Generation Internet ETF (+1.74%), ARK Space Exploration & Innovation ETF (+1.45%) and ARK Fintech Innovation ETF (+1.26%) flashed green on Tuesday, as investors’ risk appetite for technology shares replenish on strong earnings reports.

The top performer ARK Genomic Revolution ETF or ARKG, invests in industries of the health care sector, including companies involved in the biotechnology industry, mainly leaders in CRISPR, targeted therapeutics, bioinformatics, molecular diagnostics, stem cells and agricultural biology. The fund, with high exposure to North America (93%) holds 53 companies including Teladoc Health (7.98%), Exact Sciences Corp. (5.19%), Pacific Biosciences (4.91%), Fate Therapeutics (4%) and Vertex Pharmaceuticals (3.7%). Since inception on October 31st, 2014, the fund grew to $6.96 billion in assets and generated more than +300% in returns.

ARKG trades primarily on the Cboe BZX and charges an annual fee of 0.75%.

Find and compare over 7,000 ETFs with our free tools:


ę www.trackinsight.com 2021
Latest news
05:57pVoxtur to Present at the SNN Network Canada Virtual Event December 7-9, 2021
GL
05:57pAditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants
BU
05:57pINVESTOR ALERT : Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Instadose Pharma Corp. (INSD) Investors
BU
05:57pGOP Rep. Nunes leaving Congress for Trump social media firm
AQ
05:56pTesla replacing faulty Autopilot cameras in some vehicles - CNBC
RE
05:56pSHAREHOLDER ALERT : Robbins LLP Investigates Lucid Group Inc. (LCID)
BU
05:55pCelestica Announces Enhancements to Current Credit Facility
AQ
05:55pINDUSTRY COLLAB : Oregon Bio and Onward Eugene announce development partnership to grow jobs and biotech in the Willamette Valley
BU
05:54pMerck Pausing Enrollment for Two Trials of Oral Islatravir
DJ
05:54pAUSTRAL RESOURCES AUSTRALIA LTD (ASX : AR1) Signs Mining Services Contract with Thiess
AQ
Latest news